HomeClinical TopicsAbbott withdraws Meridia from market

Abbott withdraws Meridia from market

On Oct. 8, Abbott Laboratories voluntarily withdrew its weight loss drug Meridia (sibutramine) from the market in response to a request from the U.S. Food and Drug Administration. The request was based on clinical trial data that showed a higher ris for cardiovascular adverse events such as heart attack and stroke. Read more here.


Please enter your comment!
Please enter your name here

Most Recent Content